Sonic Healthcare
Sonic Healthcare offers value at 20x earnings and 4% yield. We’re looking for EPS to grow at 8% in FY27 and the stock to rerate. Target price $35

Sonic Healthcare offers value at 20x earnings and 4% yield. We’re looking for EPS to grow at 8% in FY27 and the stock to rerate. Target price $35
Sonic Healthcare offers value at 20x earnings and 4% yield. We’re looking for EPS to grow at 8% in FY27 and the stock to rerate. Target price $35
Sonic Healthcare is a counter-trend trade, so the entry point is tricky. I’m drawn to this oppertunity as it’s a high quality business with 5-10% EPS growth potential following the adjustment in post covid revenue runoff.
If you’re jumping into this one, the stop goes at today’s session low.
Sonic Healthcare Consider a long trade in SHL and place the stop loss below the $29.88 pivot low.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Or start a free thirty day trial for our full service, which includes our ASX Research.